Bio Port Korea Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	70,880	73,346	68,699
Revenue Growth (YoY)	-3.36%	6.77%	-
Cost of Revenue	53,560	52,411	49,616
Gross Profit	17,320	20,936	19,083
Selling, General & Admin	14,676	14,515	13,179
Research & Development	699.67	504.95	457.61
Amortization of Goodwill & Intangibles	31.75	9.48	9.48
Other Operating Expenses	217.85	163.69	133.25
Operating Expenses	16,490	15,696	14,164
Operating Income	830.05	5,240	4,919
Interest Expense	-310.25	-1,512	-2,108
Interest & Investment Income	557.66	517.44	408.99
Currency Exchange Gain (Loss)	-118.92	544.78	206.96
Other Non Operating Income (Expenses)	-2,808	1,467	182.24
EBT Excluding Unusual Items	-1,849	6,258	3,609
Gain (Loss) on Sale of Investments	-	18.23	-13.91
Gain (Loss) on Sale of Assets	-	-924.59	-
Pretax Income	-1,849	5,352	3,595
Income Tax Expense	-445.57	1,240	225.62
Net Income	-1,403	4,112	3,369
Net Income to Common	-1,403	4,112	3,369
Net Income Growth	-	22.04%	-
Shares Outstanding (Basic)	4	3	3
Shares Outstanding (Diluted)	4	4	4
Shares Change (YoY)	16.68%	1.04%	-
EPS (Basic)	-336.14	1465.53	1347.75
EPS (Diluted)	-336.14	1438.99	1302.58
EPS Growth	-	10.47%	-
Free Cash Flow	2,486	8,491	-1,253
Free Cash Flow Per Share	595.53	2372.83	-353.75
Gross Margin	24.44%	28.54%	27.78%
Operating Margin	1.17%	7.14%	7.16%
Profit Margin	-1.98%	5.61%	4.91%
Free Cash Flow Margin	3.51%	11.58%	-1.82%
EBITDA	3,209	7,102	6,328
EBITDA Margin	4.53%	9.68%	9.21%
D&A For EBITDA	2,378	1,862	1,409
EBIT	830.05	5,240	4,919
EBIT Margin	1.17%	7.14%	7.16%
Effective Tax Rate	-	23.16%	6.28%
Advertising Expenses	542.08	966.01	768.83

Source: S&P Capital IQ. Standard template. Financial Sources.